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a  b  s  t  r  a  c  t
The  secreted  form  of the dengue  virus  (DENV)  nonstructural-1  (NS1)  glycoprotein  has  been  shown  to  be
useful  for  the diagnosis  of  DENV  infections  in  patients’  serum  samples.  In a number  of  studies,  the  sen-
sitivity  of the  commercially  available  DENV  NS1 glycoprotein  detection  assays  was  higher  against  some
DENV  serotypes  (DENV-1  > DENV-3  >  DENV-2  = DENV-4)  than  others  and  were  also  lower  using  patients’
serum  samples  with  secondary  versus  primary  DENV  infections.  In this  study,  471 DENV-4  positive  acute
phase  patients’  serum  samples  were  selected  from  a large  panel  collected  in  Brazil  from  March  2011
to  October  2012  by  RT-PCR  and/or  virus  isolation  followed  by  serotype  determination.  The  sera  from
primary  (n =  228)  and  secondary  (n =  238)  DENV-4  infections  were  identiﬁed  using IgM  and  IgG capture
ELISAs.  The  sensitivity  of  a  commercial  DENV  NS1  glycoprotein  detection  ELISA was then  assessed  when
these  serum  samples  were  not  pre-treated  or pre-treated  by  acid or heat  dissociation  prior  to  being  tested.
Acid  and  heat  dissociation  of patients’  serum  samples  with  primary  and  secondary  DENV-4  infections
increased  signiﬁcantly  the sensitivity  of the  DENV  NS1  glycoprotein  detection  ELISA  from  54.4%  to  77.2%
(p <  0.05)  and  82%  (p <  0.05)  and  from  39.1%  to  63.9%  (p <  0.05)  and  73.1%  (p <  0.05),  respectively.  Treat-
ment  of DENV  infected  patients’  serum  samples  using  simple  and  rapid  heat  dissociation  step  (100 ◦C for
5  min)  was,  therefore,  shown  to be  very  useful  for increasing  the  sensitivity  of  the  DENV  NS1  glycoprotein
detection  ELISA  using  serum  samples  from  either  primary  or secondary  DENV  infected  patients.
©  2014  Elsevier  B.V.  All  rights  reserved.Dengue fever (DF) is a mosquito-borne viral disease of public
ealth signiﬁcance, caused by one of four dengue virus serotypes
DENV-1 to DENV-4) and mainly transmitted by Aedes aegypti
osquitoes. Hyper-endemic DENV transmission of one or more
erotypes occurs in most countries of the Americas (WHO, 2013).
n Brazil, dengue became a public health problem after the intro-
uction of DENV-1 in 1986. In July of 2010, DENV-4 was  isolated
n Roraima, 28 years after its ﬁrst detection in that same State and
oon this serotype spread other States of the country (Nogueira and
ppinghaus, 2011).
∗ Corresponding author at: Flavivirus Laboratory, Oswaldo Cruz Insti-
ute/FIOCRUZ, Av Brasil, 4365, Manguinhos, Rio de Janeiro, RJ 21045-360, Brazil.
el.: +55 21 2562 1920; fax: +55 21 2562 1779.
E-mail address: ﬂaviab@ioc.ﬁocruz.br (F.B.d. Santos).
ttp://dx.doi.org/10.1016/j.jviromet.2014.02.031
166-0934/© 2014 Elsevier B.V. All rights reserved.The DENV nonstructural-1 (NS1) glycoprotein, exists as
membrane-associated protein and secreted form and was demon-
strated to circulate in the acute phase of the disease by antigen
capture ELISAs, up to the ninth day after the onset of the symptoms
of primary and secondary infections (Alcon et al., 2002). The diag-
nostic sensitivity of the DENV NS1 glycoprotein detection ELISA
could exceed 90% for serum samples from patients with primary
DENV infections, and its circulation persisted for several days after
the fever subsided (Chaterji et al., 2011; Dussart et al., 2008; Tricou
et al., 2011). However, using serum samples from patients with sec-
ondary DENV infections, the DENV NS1 glycoprotein antigenaemia
was shown to be shorter and the detection sensitivity using this
ELISA was lower (60–80%) (Guzman et al., 2010). The anamnes-
tic IgG responses generated against this glycoprotein during the
primary DENV infection were hypothesized to account for these
ﬁndings, since the formation of circulating immune complexes
(CICs) which contained IgG-DENV NS1 glycoprotein would reduce
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he ELISA detection by both masking epitopes and increasing clear-
nce of this antigen.
In 2008, an evaluation of three commercial DENV NS1 glycopro-
ein detection assays using DENV-1, DENV-2 or DENV-3 infected
atients’ serum samples was performed in Brazil (Lima et al.,
010). Since DENV-4 subsequently re-emerged in 2010 (Nogueira
nd Eppinghaus, 2011), these assays were not tested on patients’
erum samples infected with this serotype. Therefore aimed to
valuate the sensitivity and speciﬁcity of a commercial DENV
S1glycoprotein detection assay using primary and secondary
ENV-4 infected patients’ serum samples and whether CIC dis-
ociation methods could increase the DENV-4 NS1 glycoprotein
ensitivity of this assay.
This study was performed as part of an on-going project
pproved by resolution number CSN196/96 from the Oswaldo Cruz
oundation Ethical Committee in Research (CEP 274/05), Brazil-
an Ministry of Health, after the introduction of DENV-4 into the
tate of Rio de Janeiro. The DENV infected patients’ serum samples
n = 471), used for this study, were collected from day 1 to 7 after the
nset of fever from March 2011 to October 2012. DENV-4 infections
ere conﬁrmed by virus isolation using C6/36 cell culture and sub-
equent DENV serotype determination using indirect ﬂuorescent
ntibody test (IFAT) with serotype-speciﬁc monoclonal antibod-
es (Gubler et al., 1984) and/or RT-PCR (Lanciotti et al., 1992). The
anbio dengue IgM Capture ELISA (Panbio Diagnostics, Queensland,
ustralia) was used for the qualitative detection of anti-DENV IgM
ntibodies in serum for case conﬁrmation. The IgG-ELISA previously
escribed (Miagostovich et al., 1999) was performed for the char-
cterization of dengue immune response. The Platelia Dengue NS1
g-ELISA (BioRad Laboratories, Marnes-la-Coquette, France) was
sed for NS1 antigen capture according to the instructions by the
anufacturer. In an effort to improve the Platelia Dengue NS1 Ag-
LISA test sensitivity, two antigen-antibody complex dissociation
rotocols were tested using the serum samples collected from the
ENV-4 conﬁrmed DF cases using virus isolation and/or RT-PCR, but
hich were negative using the DENV NS1 glycoprotein-detection
LISA (n = 250).
The acid dissociation method was performed as described pre-
iously (Koraka et al., 2003). Brieﬂy, 50 L of serum was added
o 50 L of dissociation buffer (1.5 M glycine/hydrochloric acid,
H 2.8) and incubated at 37 ◦C for 1 h. The dissociation reaction
as stopped by the addition of 50 L of neutralizing buffer (1.5 M
ris/hydrochloric acid, pH 9.7). The heat-mediated dissociation
ethod was performed as described previously (Schüpbach et al.,
996). Brieﬂy, 50 L of serum was added to 100 L of RNA/DNAse
ree water (Invitrogen, Carlsbad, USA) and heated in a boiling water
ath for ﬁve minutes. DENV-4 positive patients’ acute phase serum
amples were subjected to immune-complex dissociation to assess
hether these treatments could increase the sensitivity of the
ENV NS1 glycoprotein detection ELISA. The derived data was eval-
ated by chi-square test using the Epi Info 7.0.9.34 (Center for
isease Control and Prevention, Atlanta).
A total of 2468 samples from suspected DF cases were obtained
uring the collection period, of which 47.6% (1174/2468) were con-
rmed to be infected with DENV. DENV-4 was identiﬁed as the
nfecting serotype in 40.1% (471/1174) of these positive cases. The
verall DENV-4 NS1 glycoprotein detection sensitivity using the
ommercial ELISA was 46.9% (221/471). The sensitivity of DENV
S1 glycoprotein detection was therefore lower than that reported
or the DENV-4 serotype (89.6%) using patients serum samples
ollected in French Guiana (Dussart et al., 2006)or from a multi-
ountry study (67-91%) (Guzman et al., 2010).Higher DENV conﬁrmation rates were observed when the
esults from the DENV NS1 glycoprotein detection ELISA were
ombined with those obtained by either the MAC-ELISA (51.4%,
 = 0.192), DENV isolation (67.1%, p < 0.05) or the RT-PCR (99.6%,Fig. 1. Sensitivities of the different DENV detection assays used to identify the 466
DENV-4 infected patients using their serum samples collected from day 0 to 6 after
the  onset of fever.
p < 0.05) (data not shown). The DENV NS1 glycoprotein detection
ELISA showed a progressively increased sensitivity using patients
serum samples collected from day 0 (51.6%) to day 3 (68%, peak
sensitivity) before it gradually declined to 38.2% using patients’
serum samples collected on day 7 after the onset of fever (Fig. 1).
By contrast, the ability to isolate DENV-4 progressively decreased
from 77% to 24.1% using patients’ serum samples collected from
day 0 to day 7 after the onset of fever, while RT-PCR detection
which was  mainly used to select these DENV-4 infected patients’
samples was, as expected, only reduced slightly from 100% to 94%
over this same period. The sensitivity of the MAC-ELISA showed
a gradual increase using patients serum samples collected on day
0 (28.3%) to day 7 (42.3%), with 50% of these patients being pos-
itive on day 3 after the onset of fever. From the 471 DENV-4
conﬁrmed patients’ serum samples, 48.9% (228/466) were classi-
ﬁed as primary DENV infections, 51.1% (238/466) were classiﬁed
as secondary DENV infections, while the samples from 5 other
patients could not be classiﬁed (Table 1). DENV-4 NS1 glycoprotein-
positive results were obtained using the ELISA in 54.4% (124/228)
and 39.1% (93/238) of the serum samples from primary and sec-
ondary DENV infections, respectively and therefore the sensitivity
was higher for samples from primary infections (p = 0.001). Previ-
ously, higher DENV NS1 glycoprotein detection sensitivities were
observed in both primary and secondary DENV patients’ serum
samples collected in a country where severe DENV infections were
rare (Netherlands Antilles) compared to those collected from DENV
infected patients in a country (Indonesia) where severe DENV infec-
tions (DHF/DSS) were common (Koraka et al., 2003). The DENV NS1
glycoprotein dot-blot detection assay had higher sensitivities using
primary rather than secondary DENV infections in both patient
cohorts (Koraka et al., 2003) as was also found using the Platelia NS1
glycoprotein detection ELISA with DENV infected patients’ serum
samples from another DHF/DSS-endemic area (Cambodia) (Duong
et al., 2011). These results may  be explained by the presence of
Ab-DENV NS1 glycoprotein complexes in the serum samples from
patients with secondary DENV infections. By contrast, the higher
DENV NS1 glycoprotein sensitivities obtained using serum sam-
ples from Thai patients with secondary versus primary DENV-2
infections using another ELISA could be accounted for by the higher
viraemia identiﬁed in these patients (Libraty et al., 2002).
Interestingly, acid treatment/neutralization steps performed on
DENV infected patients’ serum samples collected in Indonesia
dramatically increased the DENV NS1 glycoprotein detection
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Table  1
DENV-4 NS1 glycoprotein ELISA detection sensitivities against 466 patients’ serum samples with primary or secondary dengue infections.
DENV-4 NS1 glycoprotein ELISA detection
Primary (n = 228) Secondary (n = 238)
NS1 non-dissociated NS1 dissociated P value NS1 non-dissociated NS1 dissociated P value
39.0% (93/238) Acid 63.9% (152/238) <0.05
Heat 73.1% (174/238) <0.05
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Fig. 2. Absorbance values obtained using the DENV NS1 glycoprotein detection
ELISA for each of the 250 DENV-4 NS1-negative patients’ serum samples untreated54.4%  (124/228) Acid 77.2% (176/228) <0.05 
Heat  82.0% (187/228) <0.05 
ensitivities of a dot-blot assay using samples from both primary
nd secondary infection from 64% to 91% and from 22% to 93%
espectively (Koraka et al., 2003). In a subsequent study using
atients’ serum samples collected in Thailand, the sensitivity of the
latelia DENV NS1 glycoprotein detection ELISA was  increased from
3.2% to 72% when the DENV infected patients’ serum samples were
ubjected to the same acid treatment/neutralization steps (Lapphra
t al., 2008). Moreover, acid treatment/neutralization steps per-
ormed on HIV-1 infected patients’ serum samples was previously
hown to increased dramatically the sensitivity of a HIV-1 p24 pro-
ein detection ELISA, but which could be further increased to higher
han HIV-1 RNA detection after a simple heat denaturation step,
erformed to disrupt these patients’ IgG-p24 protein immune com-
lexes (Schüpbach et al., 1996). Since a higher anti-DENV E/prM
lycoprotein IgG titres in patients’ serum samples that tested neg-
tive for the DENV-4 NS1 glycoprotein was observed (data not
hown), these samples were further tested to analyze whether
ither the acid/neutralization steps or the heat treatment steps
ould increase the NS1 glycoprotein detection sensitivity.
In this study, the sensitivity of the DENV NS1 glycoprotein
etection ELISA was increased from 54.4% (124/228) to 77.2%
176/228), p < 0.05, after the patients’ serum samples from pri-
ary DENV-4 infections were subjected to the acid dissociation
nd 82% (187/228), p < 0.05, after they had undergone heat disso-
iation (Table 1). As expected, the sensitivity of detection ELISA
sing patients’ serum samples from secondary DENV-4 infec-
ions was also increased from 39.1% (93/238) to 63.9% (152/238),
 < 0.05, after acid dissociation and to 73.1% (174/238), p < 0.05,
fter heat dissociation. Thus, there was a statistically signif-
cant difference between these sensitivities for samples from
rimary versus secondary DENV-4 patients when they were
ither non-dissociated (p = 0.001), acid dissociated (p = 0.002) or
eat dissociated (p = 0.002). The overall ELISA sensitivities, using
he combined results for samples from primary and secondary
ENV-4 infected patients, were increased signiﬁcantly from 46.6%
217/466) to 70.4% (328/466) and 77.5% (361/466), (p = 0.017) after
cid dissociation and heat dissociation, respectively.
In this study, it has been shown further evidence that acid or heat
issociation methods, as previously used for the increased ELISA
etection of the HIV-1 p24 protein (Schüpbach et al., 1996), could
oth signiﬁcantly increase the sensitivity of a commercial ELISA for
he detection of a soluble antigen of another virus (DENV-4 NS1
lycoprotein) and that heat dissociation was a superior method to
cid dissociation. This was the ﬁrst report to test the heat dissocia-
ion for the increased detection of the DENV NS1 glycoprotein and
t has shown to be an ideal method since it can be more rapidly per-
ormed than the acid dissociation method. The absorbance values
btained using the DENV NS1 glycoprotein detection ELISA for each
f the 250 DENV-4 NS1-negative patients’ serum samples untreated
non-dissociated), acid or heat dissociated are shown on Fig. 2.
Interestingly, although to a signiﬁcantly lower level than for
atients’ serum samples from secondary DENV infections, both the
cid and heat dissociation methods also increased the sensitiv-
ty of the DENV-4 NS1 glycoprotein detection using samples from
atients with primary DENV-4 infections (Table 1). These results
re therefore unlikely to be accounted for by the disruption of the(non-dissociated), acid or heat dissociated. The negative (<0.5) and positive (>1.0)
cut-off values determined at a wavelength of 450 nm are shown.
patients’ antibody-DENV-4 NS1 glycoprotein complexes, since the
DENV NS1 glycoprotein is not an immuno-dominant DENV protein
during primary DENV infections (Shu et al., 2003). Since both acid
treatment and heat treatment are known to dissociate the native
hexameric form of the DENV NS1 glycoprotein (Falconar and Young,
1990), these ﬁndings may  be due to an increased ELISA detection
sensitivity for the monomeric forms of the DENV-4 NS1 glycopro-
tein.
In this study, the usefulness of qualitative result of NS1 antigen
detection assay in early recognition of dengue infection particularly
in combination with others tests has been demonstrated. The evalu-
ation of the Platelia NS1 Ag assay exhibited a quite low sensitivity in
diagnosing DENV-4 cases. Therefore, the NS1 antigen results should
be interpreted with caution when used alone due to the false neg-
ative results and high clinical awareness and close follow-up are
still needed in patients with acute febrile illness in dengue endemic
area. Based on the results obtained, that it is suggested the addition
of a heat dissociation step on sera prior to the performance of the
NS1 assay to improve the test sensitivity on endemic areas where
secondary infections are more reported frequently.
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